By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pfenex Inc. 

5501 Oberlin Drive

San Diego  California  92121  U.S.A.
Phone: 858-352-4400 Fax: 858-352-4602



Company News
Pfenex Inc. (PFNX) Reports Second Quarter 2014 Results And Provides Business Update 9/2/2014 12:41:45 PM
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation 7/24/2014 8:06:21 AM
San Diego Biotech Pfenex Inc. Slashes Proposed Range To $8 A Share, Eyes $65 Million In IPO Debut 7/18/2014 7:09:39 AM
San Diego's Pfenex Inc. Files For A $75 Million IPO To Fund Development Of Wet AMD Drug 6/6/2014 6:35:02 AM
Pfenex Inc. Awarded Contract For Development Of Next Generation rPA-Based Anthrax Vaccine 12/17/2013 9:57:27 AM
Pfenex Inc. Awards Paragon Bioservices a Contract for cGMP Manufacturing of Its Recombinant Protective Antigen (rPA), for Phase 1 Clinical Trial of Its Anthrax Vaccine 11/5/2013 9:29:44 AM
Pfenex Inc. Awarded a Subcontract by Leidos to Develop a Scalable cGMP Production Process for a Second Key Malaria Antigen 10/29/2013 12:01:49 PM
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option With Pfenex Inc. to Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine 10/1/2013 9:32:12 AM
Pfenex Inc. Strain Engineering to Host "Strategies for Accelerating Preclinical Development of Vaccines and Therapeutic Proteins" Seminar on Aug. 20th in Boston 6/19/2013 11:57:07 AM
Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine 4/30/2013 10:21:06 AM